• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶碱的控释:7-酰基-和7,7'-酰基二茶碱衍生物的化学性质

Controlled delivery of theophylline: chemistry of 7-acyl- and 7,7'-acylditheophylline derivates.

作者信息

Bodor N, Sloan K B, Kuo Y N, Higuchi T

出版信息

J Pharm Sci. 1978 Aug;67(8):1045-50. doi: 10.1002/jps.2600670806.

DOI:10.1002/jps.2600670806
PMID:671234
Abstract

7-Acyl- and 7,7'-acylditheophylline derivatives were prepared from the reaction of theophylline with acid chlorides. In addition, a novel synthesis of these compounds was developed, which proceeds through an acylonium ion generated under mild conditions. The physical properties and stability of the derivative of choice, 7,7'-succinylditheophylline, depend on the synthetic procedure employed. This compound is a useful controlled-release prodrug of theophylline.

摘要

7-酰基和7,7'-酰基二茶碱衍生物是由茶碱与酰氯反应制备而成。此外,还开发了一种新型的这些化合物的合成方法,该方法通过在温和条件下生成的酰鎓离子进行。所选衍生物7,7'-琥珀酰二茶碱的物理性质和稳定性取决于所采用的合成方法。该化合物是一种有用的茶碱控释前药。

相似文献

1
Controlled delivery of theophylline: chemistry of 7-acyl- and 7,7'-acylditheophylline derivates.茶碱的控释:7-酰基-和7,7'-酰基二茶碱衍生物的化学性质
J Pharm Sci. 1978 Aug;67(8):1045-50. doi: 10.1002/jps.2600670806.
2
Hydrolysis and dissolution behavior of a prolonged-release prodrug of theophylline: 7,7'-succinylditheophylline.茶碱缓释前药:7,7'-琥珀酰二茶碱的水解与溶解行为
J Pharm Sci. 1979 Mar;68(3):288-95. doi: 10.1002/jps.2600680309.
3
[Metabolism of 7-(3-butynyl) theophylline in rats (author's transl)].
Arch Pharm (Weinheim). 1977 Nov;310(11):888-93. doi: 10.1002/ardp.19773101105.
4
Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
J Pharm Sci. 1988 Sep;77(9):760-4. doi: 10.1002/jps.2600770908.
5
Comparison of gastroretentive microspheres and sustained-release preparations using theophylline pharmacokinetics.利用茶碱药代动力学比较胃滞留微球与缓释制剂
J Pharm Pharmacol. 2008 Jun;60(6):693-8. doi: 10.1211/jpp.60.6.0003.
6
Per-oral controlled release dosage form of theophylline using soybean protein.使用大豆蛋白的茶碱口服控释剂型。
Drug Des Deliv. 1987 Feb;1(3):187-92.
7
[Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].一种新型口服缓释制剂中茶碱的生物利用度(作者译)
Arzneimittelforschung. 1981;31(9):1489-97.
8
Stability of theophylline elimination rate.茶碱消除率的稳定性。
Clin Pharmacol Ther. 1987 Apr;41(4):388-91. doi: 10.1038/clpt.1987.46.
9
[Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
Schweiz Med Wochenschr. 1982 Nov 20;112(47):1702-10.
10
[Prolongation of theophylline derivative release with cellulose acetate based tablets].
J Pharm Belg. 1990 Mar-Apr;45(2):111-9.

引用本文的文献

1
PURINE FUNCTIONALIZED CONGENERS AS MOLECULAR PROBES FOR ADENOSINE RECEPTORS.嘌呤功能化同系物作为腺苷受体的分子探针
Nucleosides Nucleotides. 1991;10(5):1029-1038. doi: 10.1080/07328319108047240.
2
Adenosine receptor prodrugs: towards kidney-selective dialkylxanthines.腺苷受体前药:迈向肾脏选择性二烷基黄嘌呤
J Pharmacol Exp Ther. 1989 Jul;250(1):79-85.